Arvinas to Participate in Upcoming Investor Conferences
March 04, 2025 16:05 ET
|
Arvinas Inc.
NEW HAVEN, Conn., March 04, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Breast Cancer Liquid Biopsy Market Research Report 2025: Global Market to Reach $1.1 Billion by 2030 - Rising Focus on Real-Time Cancer Monitoring and Personalized Treatment Drives Adoption
March 04, 2025 10:25 ET
|
Research and Markets
Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Liquid Biopsy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Breast Cancer Drugs Market Size is Projected to Reach USD 80.34 Billion by 2033, Growing at a CAGR of 8.90%: Straits Research
March 04, 2025 09:50 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, March 04, 2025 (GLOBE NEWSWIRE) -- Breast cancer is the prevailing ailment in the population, predominantly affecting women who are witnessing an increase in disease...
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
February 27, 2025 16:15 ET
|
Myriad Genetics, Inc.
Myriad Genetics announced a collaboration with Gabbi to provide an integrated offering for breast cancer risk assessment.
Breast Cancer Market Sees Rapid Growth — Key Insights and Forecasts of Different Breast Cancers for the Coming 10 Years | DelveInsight
February 27, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Breast Cancer Market Sees Rapid Growth — Key Insights and Forecasts of Different Breast Cancers for the Coming 10 Years | DelveInsight The breast...
Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases
February 26, 2025 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for
Patients with Leptomeningeal Metastases
Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
February 11, 2025 07:00 ET
|
Arvinas Inc.
– Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial is anticipated in 1Q25 – – Presented Phase 1b data from the TACTIVE-U sub-study of vepdegestrant in...
Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response
February 10, 2025 09:15 ET
|
IMAC Holdings, Inc.
The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection. Golden, CO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of...
Global Breast Reconstruction Surgery Market Set for Exponential Growth, Projected to Surpass USD 10,117.8 Million by 2035 witness at a CAGR of 7.5% | Future Market Insights, Inc.
February 07, 2025 06:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The global breast reconstruction surgery market is set for remarkable expansion, with market projections indicating a 7.5% CAGR from 2025 to 2035....
University Cancer & Blood Center’s Dr. Ashley Ray receives oncoplastic breast surgery certification
February 06, 2025 11:48 ET
|
University, Cancer and Blood Center
University Cancer & Blood Center (UCBC), based in Athens, Georgia, announces that Dr. Ashley Ray now has her certification in oncoplastic breast surgery.